Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 194

1.

Atrial fibrillation ablation patients have long-term stroke rates similar to patients without atrial fibrillation regardless of CHADS2 score.

Bunch TJ, May HT, Bair TL, Weiss JP, Crandall BG, Osborn JS, Mallender C, Anderson JL, Muhlestein BJ, Lappe DL, Day JD.

Heart Rhythm. 2013 Sep;10(9):1272-7. doi: 10.1016/j.hrthm.2013.07.002. Epub 2013 Jul 5.

PMID:
23835257
3.

The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.

Jacobs V, May HT, Bair TL, Crandall BG, Cutler M, Day JD, Weiss JP, Osborn JS, Muhlestein JB, Anderson JL, Mallender C, Bunch TJ.

Heart Rhythm. 2015 Apr;12(4):681-6. doi: 10.1016/j.hrthm.2014.12.034. Epub 2014 Dec 26.

PMID:
25546809
4.

Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.

Kornej J, Hindricks G, Kosiuk J, Arya A, Sommer P, Husser D, Rolf S, Richter S, Piorkowski C, Gaspar T, Lip GY, Bollmann A.

Circ Arrhythm Electrophysiol. 2013 Oct;6(5):868-74. doi: 10.1161/CIRCEP.113.000869. Epub 2013 Sep 18.

5.

Patients treated with catheter ablation for atrial fibrillation have long-term rates of death, stroke, and dementia similar to patients without atrial fibrillation.

Bunch TJ, Crandall BG, Weiss JP, May HT, Bair TL, Osborn JS, Anderson JL, Muhlestein JB, Horne BD, Lappe DL, Day JD.

J Cardiovasc Electrophysiol. 2011 Aug;22(8):839-45. doi: 10.1111/j.1540-8167.2011.02035.x. Epub 2011 Mar 15.

PMID:
21410581
6.

[Association between CHADS2 score and long-term atrial fibrillation recurrence rate after catheter ablation].

Hu X, Wang Q, Sun J, Feng X, Zhang P, Liu B, Wang J, Zhang R, Li Y.

Zhonghua Xin Xue Guan Bing Za Zhi. 2014 May;42(5):379-83. Chinese.

PMID:
25042914
7.

Risk of stroke or transient ischemic attack after atrial fibrillation ablation with oral anticoagulant use guided by ECG monitoring and pulse assessment.

Riley MP, Zado E, Hutchinson MD, Lin D, Bala R, Garcia FC, Callans DJ, Cooper JM, Verdino RJ, Dixit S, Marchlinski FE.

J Cardiovasc Electrophysiol. 2014 Jun;25(6):591-6. doi: 10.1111/jce.12387. Epub 2014 Mar 10.

PMID:
24533561
8.

Very low risk of thromboembolic events in patients undergoing successful catheter ablation of atrial fibrillation with a CHADS2 score ≤3: a long-term outcome study.

Saad EB, d'Avila A, Costa IP, Aryana A, Slater C, Costa RE, Inácio LA Jr, Maldonado P, Neto DM, Camiletti A, Camanho LE, Polanczyk CA.

Circ Arrhythm Electrophysiol. 2011 Oct;4(5):615-21. doi: 10.1161/CIRCEP.111.963231. Epub 2011 Aug 13.

9.

Warfarin is not needed in low-risk patients following atrial fibrillation ablation procedures.

Bunch TJ, Crandall BG, Weiss JP, May HT, Bair TL, Osborn JS, Anderson JL, Lappe DL, Muhlestein JB, Nelson J, Allison S, Foley T, Anderson L, Day JD.

J Cardiovasc Electrophysiol. 2009 Sep;20(9):988-93. doi: 10.1111/j.1540-8167.2009.01481.x. Epub 2009 May 15.

PMID:
19473299
10.

Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE) randomized trial.

Di Biase L, Burkhardt JD, Santangeli P, Mohanty P, Sanchez JE, Horton R, Gallinghouse GJ, Themistoclakis S, Rossillo A, Lakkireddy D, Reddy M, Hao S, Hongo R, Beheiry S, Zagrodzky J, Rong B, Mohanty S, Elayi CS, Forleo G, Pelargonio G, Narducci ML, Dello Russo A, Casella M, Fassini G, Tondo C, Schweikert RA, Natale A.

Circulation. 2014 Jun 24;129(25):2638-44. doi: 10.1161/CIRCULATIONAHA.113.006426. Epub 2014 Apr 17.

11.

Incidence and predictors of periprocedural cerebrovascular accident in patients undergoing catheter ablation of atrial fibrillation.

Scherr D, Sharma K, Dalal D, Spragg D, Chilukuri K, Cheng A, Dong J, Henrikson CA, Nazarian S, Berger RD, Calkins H, Marine JE.

J Cardiovasc Electrophysiol. 2009 Dec;20(12):1357-63. doi: 10.1111/j.1540-8167.2009.01540.x.

PMID:
19572951
12.

CHADS2 and CHA2DS2-VASc scores as predictors of left atrial ablation outcomes for paroxysmal atrial fibrillation.

Letsas KP, Efremidis M, Giannopoulos G, Deftereos S, Lioni L, Korantzopoulos P, Vlachos K, Xydonas S, Kossyvakis C, Sideris A.

Europace. 2014 Feb;16(2):202-7. doi: 10.1093/europace/eut210. Epub 2013 Jun 28.

PMID:
23813452
13.

Comparison of CHADS2, R2CHADS2, and CHA2DS2-VASc scores for the prediction of rhythm outcomes after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.

Kornej J, Hindricks G, Kosiuk J, Arya A, Sommer P, Husser D, Rolf S, Richter S, Huo Y, Piorkowski C, Bollmann A.

Circ Arrhythm Electrophysiol. 2014 Apr;7(2):281-7. doi: 10.1161/CIRCEP.113.001182. Epub 2014 Mar 8.

14.

Subtle post-procedural cognitive dysfunction after atrial fibrillation ablation.

Medi C, Evered L, Silbert B, Teh A, Halloran K, Morton J, Kistler P, Kalman J.

J Am Coll Cardiol. 2013 Aug 6;62(6):531-9. doi: 10.1016/j.jacc.2013.03.073. Epub 2013 May 15.

15.

Five-year outcomes of catheter ablation in patients with atrial fibrillation and left ventricular systolic dysfunction.

Bunch TJ, May HT, Bair TL, Jacobs V, Crandall BG, Cutler M, Weiss JP, Mallender C, Osborn JS, Anderson JL, Day JD.

J Cardiovasc Electrophysiol. 2015 Apr;26(4):363-70. doi: 10.1111/jce.12602. Epub 2015 Feb 11.

PMID:
25534572
16.

Patients With Ischemic Stroke and Incident Atrial Fibrillation: A Nationwide Cohort Study.

Fauchier L, Clementy N, Pelade C, Collignon C, Nicolle E, Lip GY.

Stroke. 2015 Sep;46(9):2432-7. doi: 10.1161/STROKEAHA.115.010270. Epub 2015 Aug 6.

17.

R2CHADS2 score and thromboembolic events after catheter ablation of atrial fibrillation in comparison with the CHA2DS2-VASc score.

Chao TF, Lin YJ, Chang SL, Lo LW, Hu YF, Tuan TC, Liao JN, Chung FP, Hsieh MH, Chen SA.

Can J Cardiol. 2014 Apr;30(4):405-12. doi: 10.1016/j.cjca.2014.01.005. Epub 2014 Jan 13.

PMID:
24582725
18.

The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.

Roldán V, Marín F, Manzano-Fernández S, Gallego P, Vílchez JA, Valdés M, Vicente V, Lip GY.

J Am Coll Cardiol. 2013 Dec 10;62(23):2199-204. doi: 10.1016/j.jacc.2013.08.1623. Epub 2013 Sep 18.

19.

Comparative Performance of ATRIA, CHADS2, and CHA2DS2-VASc Risk Scores Predicting Stroke in Patients With Atrial Fibrillation: Results From a National Primary Care Database.

van den Ham HA, Klungel OH, Singer DE, Leufkens HG, van Staa TP.

J Am Coll Cardiol. 2015 Oct 27;66(17):1851-9. doi: 10.1016/j.jacc.2015.08.033.

20.

Risk of atrial fibrillation, stroke, and death after radiofrequency catheter ablation of typical atrial flutter.

Seara JG, Roubin SR, Gude Sampedro F, Barreiro VB, Sande JM, Mañero MR, Grandio PC, Alvarez B, Juanatey JG.

Clin Res Cardiol. 2014 Jul;103(7):543-52. doi: 10.1007/s00392-014-0682-6. Epub 2014 Feb 25.

PMID:
24566731

Supplemental Content

Support Center